Boris Hejblum

Title: The Innovative Contributions of Boris Hejblum

Introduction

Boris Hejblum is a notable inventor based in Talence, France. He has made significant contributions to the field of medical research, particularly in the area of omega-3 polyunsaturated fatty acids. His work has implications for understanding retinal health and its correlation with cholesterol esters.

Latest Patents

Boris Hejblum holds a patent for the "Prediction of the content of omega-3 polyunsaturated fatty acids in the retina by measuring 7 cholesterol ester molecules." This invention relates to a method for determining the content of omega-3 polyunsaturated fatty acids in the retina of a subject. The method involves measuring the content of at least one cholesteryl ester in a blood sample, which is correlated to the omega-3 fatty acid content in the retina. Specifically, the cholesteryl ester used in this method is cholesteryl 5,8,11,14,17-eicosapentaenoate. Hejblum's innovative approach provides a valuable tool for assessing retinal health.

Career Highlights

Throughout his career, Boris Hejblum has worked with esteemed institutions such as Université de Bordeaux and the National Institute of Health and Medical Research. His research has focused on the intersection of biochemistry and ophthalmology, contributing to advancements in medical diagnostics.

Collaborations

Boris has collaborated with notable colleagues, including Cécile Delcourt and Niyazi Acar. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Boris Hejblum's contributions to the field of medical research, particularly through his patent on omega-3 fatty acids and cholesterol esters, highlight his innovative spirit and dedication to advancing healthcare. His work continues to influence the understanding of retinal health and its relationship with dietary components.